Fundraising Fox
OncoLux
1 known investors
Find your way into OncoLux
Sign up to see every warm intro you have to OncoLux
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OncoLux team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OncoLux develops an optical theranostic system that gives surgeons intraoperative enhanced visualization of residual cancer and combines it with optical photodynamic therapy to treat remaining tumor tissue during surgery. The technology targets cancer surgery patients and clinicians in the medical device field.
Founders & leadership
AK
Alan KerseyCEOAlan Kersey is CEO of OncoLux, which develops an optical theranostic system for intraoperative cancer visualization and photodynamic therapy during surgical procedures.
Investors · 1
Founder mafia
2 people who came through OncoLux went on to found or lead other companies.
Related companies · 4
OncosenxOncoSenX is a late-stage pre-clinical cancer therapeutics company developing treatments that target solid tumors based on transcriptional activity. Its system pairs a patented Proteo-Lipid Vehicle (PLV) delivery agent with plasmid DNA payloads that induce apoptosis in cancer cells while sparing adjacent cells.
ExelixisExelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.
Oncotelic TherapeuticsOncotelic is a biopharmaceutical company developing oncology therapeutics, including immuno-oncology and nanomedicine approaches, and applying AI technology to drug development. It focuses on cancer treatments and other therapeutic areas.
StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Companies working in the same space as OncoLux.
Frequently asked questions
- What does OncoLux do?
- OncoLux develops an optical theranostic system that gives surgeons intraoperative enhanced visualization of residual cancer and combines it with optical photodynamic therapy to treat remaining tumor tissue during surgery. The technology targets cancer surgery patients and clinicians in the medical device field.
- Who are OncoLux's investors?
- OncoLux's investors include Connecticut Innovations.